{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T09:26:58Z","timestamp":1777973218926,"version":"3.51.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1053\/j.ajkd.2019.05.016","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T08:37:13Z","timestamp":1564562233000},"page":"844-848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Novel Detection of CALR-Mutated Cells in Myeloproliferative Neoplasm-Related Glomerulopathy With Interstitial Extramedullary Hematopoiesis: A Case Report"],"prefix":"10.1053","volume":"74","author":[{"given":"Keisuke","family":"Maruyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayana","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Kabara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoki","family":"Matsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiro","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sari","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yayoi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Hasebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1053\/j.ajkd.2019.05.016_bib1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.leukres.2006.12.002","volume":"31","author":"Mesa","year":"2007","journal-title":"Leuk Res"},{"issue":"7","key":"10.1053\/j.ajkd.2019.05.016_bib2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ki.2011.147","article-title":"Myeloproliferative neoplasms cause glomerulopathy","volume":"80","author":"Said","year":"2011","journal-title":"Kidney Int"},{"issue":"12","key":"10.1053\/j.ajkd.2019.05.016_bib3","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/modpathol.2015.117","article-title":"Renal extramedullary hematopoiesis: interstitial and glomerular pathology","volume":"28","author":"Alexander","year":"2015","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1053\/j.ajkd.2019.05.016_bib4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1200\/JCO.2010.32.2446","article-title":"DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status","volume":"29","author":"Gangat","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1053\/j.ajkd.2019.05.016_bib5","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.humpath.2006.12.011","article-title":"Increased angiogenesis in chronic idiopathic myelofibrosis: vascular endothelial growth factor as a prominent angiogenic factor","volume":"38","author":"Steurer","year":"2007","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1053\/j.ajkd.2019.05.016_bib6","first-page":"1","article-title":"Bone marrow fibrosis in primary myelofibrosis: pathogenic mechanisms and the role of TGF-beta","volume":"3","author":"Agarwal","year":"2016","journal-title":"Stem Cell Invest"},{"issue":"4","key":"10.1053\/j.ajkd.2019.05.016_bib7","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1523-1755.2005.00574.x","article-title":"The cyclin-dependent kinase inhibitor p21 is required for TGF-beta1-induced podocyte apoptosis","volume":"68","author":"Wada","year":"2005","journal-title":"Kidney Int"},{"issue":"25","key":"10.1053\/j.ajkd.2019.05.016_bib8","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","article-title":"Somatic mutations of calreticulin in myeloproliferative neoplasms","volume":"369","author":"Klampfl","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2019.05.016_bib9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.pathol.2016.03.002","article-title":"Mutation specific immunohistochemistry is highly specific for the presence of calreticulin mutations in myeloproliferative neoplasms","volume":"48","author":"Andrici","year":"2016","journal-title":"Pathology"},{"issue":"10","key":"10.1053\/j.ajkd.2019.05.016_bib10","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/ajh.24425","article-title":"MR imaging in non-hepatosplenic extramedullary hematopoiesis in primary myelofibrosis","volume":"91","author":"Calistri","year":"2016","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1053\/j.ajkd.2019.05.016_bib11","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/bjh.13644","article-title":"Ruxolitinib is an effective treatment for CALR-positive patients with myelofibrosis","volume":"173","author":"Guglielmelli","year":"2016","journal-title":"Br J Haematol"},{"issue":"121","key":"10.1053\/j.ajkd.2019.05.016_bib12","first-page":"1","article-title":"Primary myelofibrosis\u00a0associated glomerulopathy: significant improvement after therapy with ruxolitinib","volume":"16","author":"Rajasekaran","year":"2015","journal-title":"BMC Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2019.05.016_bib13","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1053\/j.ajkd.2017.06.022","article-title":"Membranous nephropathy and intrarenal extramedullary hematopoiesis in a patient with myelofibrosis","volume":"70","author":"Philipponnet","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2019.05.016_bib14","first-page":"70","article-title":"Nephrotic syndrome in primary myelofibrosis with renal extramedullary hematopoiesis and glomerulopathy in the JAK inhibitor era","volume":"5","author":"Del Sordo","year":"2017","journal-title":"Clin Nephrol Case Stud"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638619308273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638619308273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:23:47Z","timestamp":1759461827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638619308273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0272638619308273"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2019.05.016","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Detection of CALR-Mutated Cells in Myeloproliferative Neoplasm-Related Glomerulopathy With Interstitial Extramedullary Hematopoiesis: A Case Report","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2019.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}